Rapamycin No More: Bryan Johnson Parts Ways with Controversial Anti-Aging Drug
Tech entrepreneur Bryan Johnson, known for his rigorous anti-aging regimen, has decided to stop using the drug rapamycin due to health risks outweighing its potential benefits. Despite facing criticism, Johnson's decision was backed by Aravind Srinivas, CEO of Perplexity AI. This move may significantly impact the anti-aging industry, sparking a shift towards safer alternatives.
Jan 17